NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
May 06, 2024 at 08:13 pm IST
Share
EMERYVILLE - NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2024 after market close on Thursday, May 9, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.
Date/Time: Thursday, May 9, 4:30 p.m. ET / 1:30 p.m. PT
Pre-Registration
Participants can pre-register for the conference call here: Callers who pre-register will be emailed conference details and unique Registration ID to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.
Dial In: Those who choose not to pre-register can access the live conference call by dialing the following and requesting conference call ID# 85516: 888-500-3691 from within the U.S., 646-307-1951 from outside the U.S.
The live webcast of the conference call also will be available on the Events section of the Company website. A replay of the call will be available beginning three hours after its completion through June 9, 2024 by dialing 877-660-6853 from within the U.S. or 201-612-7415 from outside the U.S., and entering conference ID 13746453.
About NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare, skincare and wound care products. NovaBay's leading product Avenova Antimicrobial Lid & Lash Solution is often prescribed by eyecare professionals for blepharitis and dry-eye disease and is also available directly to consumers through online distribution channels such as Amazon.com. NovaBay also manufactures and sells effective, yet gentle and non-irritating wound care products. The PhaseOne brand is distributed through commercial partners in the U.S. for professional use only, and the NeutroPhase brand is distributed in China by China Pioneer Pharma Holdings, Limited.
NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and wound care products. Its product, Avenova Antimicrobial Lid and Lash Solution, has antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. It offers a portfolio of products for each step of the standard at home treatment regimen, including the Avenova Eye Health Support antioxidant-rich oral supplement, Avenova Lubricating Eye Drops for instant relief, NovaWipes by Avenova, Avenova Warm Eye Compress to soothe the eyes, and the i-Chek by Avenova to monitor physical eyelid health. It also manufactures and sells its proprietary form of hypochlorous acid for the wound care market with its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers and other injuries.